← FDA DRUG APPROVALS

FDA ANDA · ANDA065228

AMOXICILLIN

Sponsor: SANDOZ

APPLICATION
ANDA065228
TYPE
ANDA
ORIGINAL APPROVAL
2005-07-13
LATEST ACTION
2024-05-01
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

AMOXICILLINPrescription
AMOXICILLIN 875MG · TABLET · ORAL
AMOXICILLINPrescription
AMOXICILLIN 500MG · TABLET · ORAL

Approval history

2024-05-01Labeling · Supplement 20 · standardAP
2024-04-25Labeling · Supplement 19 · standardAP
2024-04-25Labeling · Supplement 17 · standardAP
2020-06-03Labeling · Supplement 11 · standardAP
2020-06-03Labeling · Supplement 12 · standardAP
2014-11-25Labeling · Supplement 7 · standardAP
2013-02-22Labeling · Supplement 6 · standardAP
2005-07-13OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →